AdvertisementEli Lilly releases more data for new obesity drug, moving toward fast-track approvalApril 27, 2023Allison AubreyfacebookEmailEli Lilly is seeking FDA approval for tirzepatide for chronic weight management. The drug could be approved by the end of the year. (Eli Lilly & co.)
